Skip to main content
. 2018 Jul 3;9:2587. doi: 10.1038/s41467-018-04983-2

Fig. 2.

Fig. 2

Biosynthesis of novofumigatonin. a Proposed biosynthetic pathway of novofumigatonin (1). Boxed compounds were isolated in this study. Detailed procedures for isolation and structural determination of the metabolites are provided in the Supplementary Notes 1 to 18. b LC–MS analysis of metabolites from gene-deletion mutants. Extracted ion chromatograms (EICs) at m/z 423.251 (for 4), 431.243 (for 5), 431.279 (for 11), 445.259 (for 12), 447.275 (for 2), 457.256 (for 6), 461.217 (for 1), 465.248 (for 15 and 18), 477.212 (for 19), and 495.259 (for 14), are shown. c LC–MS analysis after the deletion of e-anaPS. Base peak chromatograms are shown. d HPLC analysis of the metabolites from A. oryzae transformants. Chromatograms were monitored at 300 nm. e, f LC–MS analyses of the metabolites from A. oryzae transformants. The structures of compounds 21 and 22 are shown in Fig. 4